ISOGENICA PUSHES INTO JAPAN
Isogenica, based at the heart of the Cambridge UK BioMedTech
cluster, has made a decisive move to open up Japan as a market for
its innovative technology for antibody, protein and peptide
The Chesterford Research Park company has appointed CTC
Laboratory Systems Corporation (CTCLS) of Tokyo to represent the
business in Japan.
CTCLS is a leading force in the pharmaceutical research market
in Japan and has been tasked with finding a new customer base in
the territory for Isogenica.
To red the full article, please click
Source - http://www.businessweekly.co.uk/